Blinatumomab Consolidation in Real World
NCT07117136
This study is recruiting at 5 US sites in 4 states, according to its ClinicalTrials.gov record last updated .
Summary
This will be a multi-center registry for patients with B-ALL. Patient data will be collected both retrospectively and prospectively. The data forms and surveys will be built and managed through REDCap, a secure web application managed by the Clinical \& Translational Science Institute.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- B-Cell Acute Lymphoblastic Leukaemia
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Medical College of Wisconsin
- Last updated on ClinicalTrials.gov
- October 1, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Florida · 1
- Mayo Clinic Cancer Center · Jacksonville, FL
Illinois · 2
- Northwestern University · Chicago, IL
- The University of Chicago · Chicago, IL
Pennsylvania · 1
- University of Pennsylvania · Philadelphia, PA
Wisconsin · 1
- Medical College of Wisconsin · Milwaukee, WI
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.